QSAR and QSTR study of selenocyanate derivatives to improve their therapeutic index as anti-leishmanial agents
- 13 July 2013
- journal article
- research article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 23 (2) , 818-826
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Selenocyanates and diselenides: A new class of potent antileishmanial agentsEuropean Journal of Medicinal Chemistry, 2011
- Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugsParasitology Research, 2007
- Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica ParasitesPLOS Medicine, 2006
- Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agentsBioorganic & Medicinal Chemistry, 2005
- Leishmaniasis– current chemotherapy and recent advances in the search for novel drugsTrends in Parasitology, 2003
- QSAR and 3D QSAR in drug design Part 2: applications and problemsDrug Discovery Today, 1997
- QSAR and 3D QSAR in drug design Part 1: methodologyDrug Discovery Today, 1997
- Quantitative Structure-Activity Relationships for 1,4-Dihydropyridine Calcium Channel Antagonists (Nifedipine Analogues): A Quantum ChemicalKlassical ApproachJournal of Pharmaceutical Sciences, 1994
- Quantitative approach to biochemical structure-activity relationshipsAccounts of Chemical Research, 1969
- p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical StructureJournal of the American Chemical Society, 1964